0000950170-24-017071.txt : 20240220
0000950170-24-017071.hdr.sgml : 20240220
20240220160017
ACCESSION NUMBER: 0000950170-24-017071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240220
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sperzel John J III
CENTRAL INDEX KEY: 0001602618
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 24653089
MAIL ADDRESS:
STREET 1: 61 CRESTVIEW LANE
CITY: BRUNSWICK
STATE: ME
ZIP: 04011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
ownership.xml
4
X0508
4
2024-02-20
0001492674
T2 Biosystems, Inc.
TTOO
0001602618
Sperzel John J III
101 HARTWELL AVENUE
LEXINGTON
MA
02421
true
true
false
false
See Remarks
false
Common Stock
2024-02-20
4
M
false
160
A
333
D
Restricted Stock Units
2024-02-20
4
M
false
160
0
D
Common Stock
160
160
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
On February 20, 2022 the reporting person was granted 480 RSU's that vest in three equal annual installments commencing on February 20, 2023
Chairman, President and Chief Executive Officer
/s/ John Sprague, Attorney-in-fact
2024-02-20